Evidence map›Paper›PMID 33351789›Full record

ArticleJCI insight2021

An early endothelial cell-specific requirement for Glut1 is revealed in Glut1 deficiency syndrome model mice.

Maoxue Tang, Sarah H Park, Sabrina Petri, Hang Yu, Carlos B Rueda, E Dale Abel, Carla Y Kim, Elizabeth Mc Hillman, Fanghua Li, Yeojin Lee and 5 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Toward a working definition of ketogenic diet resistance in GLUT1 deficiency syndrome.Epileptic disorders : international epilepsy journal with videotape · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Lower GLUT1 and unchanged MCT1 in Alzheimer's disease cerebrovasculature.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Metabolic Transporters in the Peripheral Nerve-What, Where, and Why?Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Maoxue TangDepartment of Neurology and.
Sarah H ParkDepartment of Neurology and.
Sabrina PetriDepartment of Genetics & Development and the Institute for Genomic Medicine, Columbia University, New York, New York, USA.
Hang YuDepartments of Biomedical Engineering and Radiology, Mortimer B. Zuckerman Mind Brain Behavior Institute and Kavli Institute for Brain Science, Columbia University, New York, New York, USA.
Carlos B RuedaDepartment of Neurology and.
E Dale AbelFraternal Order of Eagles Diabetes Research Center and Division of Endocrinology and Metabolism, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Carla Y KimDepartments of Biomedical Engineering and Radiology, Mortimer B. Zuckerman Mind Brain Behavior Institute and Kavli Institute for Brain Science, Columbia University, New York, New York, USA.
Elizabeth Mc HillmanDepartments of Biomedical Engineering and Radiology, Mortimer B. Zuckerman Mind Brain Behavior Institute and Kavli Institute for Brain Science, Columbia University, New York, New York, USA.
Fanghua LiDepartment of Neurology and.
Yeojin LeeColumbia Stem Cell Initiative and Department of Microbiology & Immunology, Columbia University Irving Medical Center, New York, New York, USA.
Lei DingColumbia Stem Cell Initiative and Department of Microbiology & Immunology, Columbia University Irving Medical Center, New York, New York, USA.
Smitha JagadishRare & Neurological Diseases Research, Sanofi Genzyme, Framingham, Massachusetts, USA.
Wayne N FrankelDepartment of Genetics & Development and the Institute for Genomic Medicine, Columbia University, New York, New York, USA.
Darryl C De VivoDepartment of Neurology and.
Umrao R MonaniDepartment of Neurology and.
Columbia University Irving Medical Center · USAllen Institute for Brain Science · USNew York Genome Center · USFraternal Order of Eagles · USSanofi (France) · FR

Funding

Genetic Determinants of Epilepsy in Murine SystemsR37NS031348 · NINDS · JACKSON LABORATORY · PI FRANKEL, WAYNE N. · 2014 to 2020
$5.8M
Decoding the neural basis of resting-state functional connectivity mappingRF1MH114276 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HILLMAN, ELIZABETH M. C. · 2017 to 2017
$4.2M
In-vivo optical imaging of neurovascular coupling and cerebral metabolismR01NS063226 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HILLMAN, ELIZABETH M. C. · 2008 to 2019
$3.5M
Spinal muscular atrophy: Mechanisms & treatment strategies.R01NS104218 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MONANI, UMRAO · 2019 to 2022
$2.0M
Regulation of hematopoietic stem cells and leukemia stem cells by thrombopoietinR01HL132074 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DING, LEI · 2016 to 2020
$2.0M
Imaging the neuronal and metabolic basis of resting state connectivity mappingR01NS076628 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HILLMAN, ELIZABETH M. C. · 2011 to 2015
$1.7M
NHLBI NIH HHS R01 HL132074NIMH NIH HHS RF1 MH114276NINDS NIH HHS R01 NS063226NINDS NIH HHS R01 NS076628NINDS NIH HHS R01 NS104218
6 · The paper itself

Abstract

Paucity of the glucose transporter-1 (Glut1) protein resulting from haploinsufficiency of the SLC2A1 gene arrests cerebral angiogenesis and disrupts brain function to cause Glut1 deficiency syndrome (Glut1 DS). Restoring Glut1 to Glut1 DS model mice prevents disease, but the precise cellular sites of action of the transporter, its temporal requirements, and the mechanisms linking scarcity of the protein to brain cell dysfunction remain poorly understood. Here, we show that Glut1 functions in a cell-autonomous manner in the cerebral microvasculature to affect endothelial tip cells and, thus, brain angiogenesis. Moreover, brain endothelial cell-specific Glut1 depletion not only triggers a severe neuroinflammatory response in the Glut1 DS brain, but also reduces levels of brain-derived neurotrophic factor (BDNF) and causes overt disease. Reduced BDNF correlated with fewer neurons in the Glut1 DS brain. Controlled depletion of the protein demonstrated that brain pathology and disease severity was greatest when Glut1 scarcity was induced neonatally, during brain angiogenesis. Reducing Glut1 at later stages had mild or little effect. Our results suggest that targeting brain endothelial cells during early development is important to ensure proper brain angiogenesis, prevent neuroinflammation, maintain BDNF levels, and preserve neuron numbers. This requirement will be essential for any disease-modifying therapeutic strategy for Glut1 DS.

Indexed as

AnimalsAnimals, NewbornBrainBrain-Derived Neurotrophic FactorCarbohydrate Metabolism, Inborn ErrorsDisease Models, AnimalEndothelial CellsFemaleGene Knockdown TechniquesGlucose Transporter Type 1HaploinsufficiencyMaleMiceMice, 129 StrainMice, KnockoutMonosaccharide Transport ProteinsBdnf protein, mouseBrain-Derived Neurotrophic FactorGlucose Transporter Type 1Monosaccharide Transport ProteinsSlc2a1 protein, mouseMonogenic diseasesMouse modelsNeurological disordersNeuroscience

Identifiers

PMID33351789
PMCPMC7934852
OpenAlexW3116458948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.